Danny Nejad Khalil

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute. Active years: 2026.

USPTO Granted Patents = 1 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 1

Company Filing History:

1 out of 618

Memorial Sloan Kettering Cancer Center

patents

1 out of 11

Tri-Institutional Therapeutics Discovery Institute

patents

where one patent can have more than one assignee

Years Active: 2026

Loading Chart...

1 patent (USPTO):Sort by Forward CitationsExplore Patents

1. 12747299 - CD40 BINDING MOLECULES AND USES THEREOF (2026-09-29),

Profile summary based on public USPTO records.